New diabetes clinical trial: A Randomized Post-Market Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating Diabetic Foot Ulcers (DFU) and SanoGraft® in Treating Venous Leg Ulcers (VLU) to SOC Treatment

Published on: July 22, 2024 at 11:00PM
Conditions: Diabetic Foot Ulcer; Venous Leg Ulcer
Interventions: Other: SanoGraft; Other: PelloGraft
Sponsors: Surgenex
Recruiting
https://ift.tt/HfNMXup

Comments